RESUMEN
New approach to peritoneal carcinomatosis combining cytoreductive surgery and hypertermic intraperitoneal chemotherapy suggest improved survival when it is possible to achieve a complete cytoreduction. In this study we consider the major complications related to this procedure and purpose our approach for their prevention and treatment.
Asunto(s)
Quimioterapia del Cáncer por Perfusión Regional , Hipertermia Inducida , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/cirugía , Complicaciones Posoperatorias/etiología , Quimioterapia del Cáncer por Perfusión Regional/efectos adversos , Terapia Combinada , Humanos , Hipertermia Inducida/efectos adversos , Complicaciones Posoperatorias/prevención & control , Complicaciones Posoperatorias/terapiaRESUMEN
New approach in treatment of peritoneal carcinomatosis combining cytoreductive surgery and intraperitoneal chemotherapy suggests improved survival when it is possible to achieve a complete cytoreduction. In this study we consider the carcinomatosis from colorectal and appendiceal adenocarcinoma. In all cases, patients in whom cytoreductive surgery was complete had a median survival much longer compared with patients in whom was not possible and, as perfusion works on minimal residual disease, peritonectomy is the only surgical technique that aim at total removal of parietal and visceral peritoneal lesions.